Hosted on MSN2mon
Johnson & Johnson ketamine-derived nasal spray gets FDA approval for depression, but JNJ stock dips on earnings
On Tuesday, the Food and Drug Administration (FDA) approved Johnson & Johnson’s nasal spray, Spravato (esketamine), to treat major depressive disorder. Oral antidepressants are the most common ...
Yahoo Finance6d
FDA approves Johnson & Johnson’s Tremfya to treat Crohn’s disease
Johnson & Johnson (J&J ... In January, 2025, J&J’s nasal spray Spravato secured a label expansion from the FDA for use as a single agent in adults with major depressive disorder (who were ...
WGN-TV7mon
FDA approves first nasal spray to treat dangerous allergic reactions
CEO/Founder Nicole Tinson and Senior Vice President of Programs and Partnership Dr. Dennis Johnson, who is a native of Chicago's South Side, joined Jewell Hillery via Zoom on Sunday's WGN Weekend ...
pharmaphorum8mon
J&J files to expand label of depression drug Spravato
Johnson & Johnson has filed for FDA approval of its antidepressant nasal spray Spravato, hoping to make it the first standalone treatment for adults with treatment-resistant depression (TRD).
WKRN-TV6mon
FDA approves at-home nasal spray flu vaccine
An Oakland High School student has been charged with a felony for reportedly bringing a loaded handgun to school, prompting a lockdown of the school on Friday, March 21. A former music producer ...
Altoona Mirror1y
FDA declines to approve nasal spray
using the company’s nasal spray device compared with injections. The move comes four months after an FDA advisory committee recommended approval of the device, dubbed neffy. The FDA is not ...
FOX31 Denver1y
FDA approves over-the-counter naloxone nasal spray
Debra Rankin has dedicated her life to education, and she said the biggest honor is seeing kids become strong learners. The Colorado Rockies have been playing at Coors Field for 30 years. This ...
Healio21d
FDA approves epinephrine nasal spray for children aged as young as 4 years
Payment options are available based on insurance coverage. The FDA has approved neffy 1 mg epinephrine nasal spray for treating anaphylaxis and other type 1 allergic reactions in children aged 4 ...
US FDA expands use of ARS Pharma's allergic reaction nasal spray in 15-30 kg patients
The U.S. Food and Drug Administration approved the expanded use of ARS Pharmaceuticals' nasal spray for severe allergic reactions in patients who weigh between 15 and 30 kilograms, the company said on ...
Benzinga.com21d
3SPRY : FDA Approves ARS Pharmaceuticals' Lower Dose Neffy Nasal Spray...
FDA approves Neffy 1 mg for children aged 4+ weighing 15 to <30 kg for allergic reactions. Most insured patients can access Neffy for $25, while cash price is $199 for two doses. Feel unsure about ...
Nasdaq14d
Milestone Pharmaceuticals Reports FDA PDUFA Review Date for CARDAMYST™ Nasal Spray Targeting PSVT, Plans for Mid-2025 Launch
Milestone Pharmaceuticals Inc. announced that the FDA has ... for its nasal spray CARDAMYST™ (etripamil), aimed at treating Paroxysmal Supraventricular Tachycardia (PSVT). If approved, Milestone ...